Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and transmissible spongiform encephalopathies (TSEs), share fundamental mechanisms of protein misfolding, synaptic dysfunction, and progressive neuronal loss. The cellular prion protein (PrPC), long viewed through the lens of prion biology, is now recognized as a pleiotropic modulator of neuronal physiology and a central interaction hub for amyloidogenic proteins. PrPC undergoes tightly regulated proteolytic processing (α-, β-, γ-cleavage, and ectodomain shedding), generating soluble fragments and peptides with distinct and sometimes opposing biological activities. These derivatives modulate neurotrophic signaling, oxidative stress responses, and the uptake/toxicity of Alzheimer’s disease-relevant soluble amyloid-β (Aβ), α‑synuclein, and tau. Recent work highlights PrPC as a ligand for low-density lipoprotein receptor‑related protein‑1 (LRP1) and the NMDA receptor (NMDAR), with shed PrPC and PrP‑derived peptides capable of initiating cell signaling and attenuating inflammatory responses, including when PrPC is delivered via extracellular vesicles. In parallel, ultrasensitive seed amplification assays (SAA; RT‑QuIC/PMCA) have transformed prion diagnostics and underscore the biomarker potential of both full-length PrPC and of its proteolytic fragments. Here, we synthesize current knowledge on PrPC structure–function relationships, proteolytic processing, and crosstalk with disease‑ associated protein aggregates. We also outline emerging translational opportunities, ranging from PrP‑derived peptide therapeutics to fluid-based biomarkers that track disease onset and progression.

Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers / Mari E., Aventaggiato M., Paldino E., Ceccarelli S., Mucci N., Bellomo G., Mantuano E., Dugheri S., Martellucci S., Mattei V.. - In: CELL & BIOSCIENCE. - ISSN 2045-3701. - ELETTRONICO. - 16:(2026), pp. 105.0-105.0. [10.1186/s13578-026-01609-9]

Cellular prion protein and its derived peptides: multifaceted roles in neurodegenerative diseases and potential as biomarkers

Mucci N.;Dugheri S.;
2026

Abstract

Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and transmissible spongiform encephalopathies (TSEs), share fundamental mechanisms of protein misfolding, synaptic dysfunction, and progressive neuronal loss. The cellular prion protein (PrPC), long viewed through the lens of prion biology, is now recognized as a pleiotropic modulator of neuronal physiology and a central interaction hub for amyloidogenic proteins. PrPC undergoes tightly regulated proteolytic processing (α-, β-, γ-cleavage, and ectodomain shedding), generating soluble fragments and peptides with distinct and sometimes opposing biological activities. These derivatives modulate neurotrophic signaling, oxidative stress responses, and the uptake/toxicity of Alzheimer’s disease-relevant soluble amyloid-β (Aβ), α‑synuclein, and tau. Recent work highlights PrPC as a ligand for low-density lipoprotein receptor‑related protein‑1 (LRP1) and the NMDA receptor (NMDAR), with shed PrPC and PrP‑derived peptides capable of initiating cell signaling and attenuating inflammatory responses, including when PrPC is delivered via extracellular vesicles. In parallel, ultrasensitive seed amplification assays (SAA; RT‑QuIC/PMCA) have transformed prion diagnostics and underscore the biomarker potential of both full-length PrPC and of its proteolytic fragments. Here, we synthesize current knowledge on PrPC structure–function relationships, proteolytic processing, and crosstalk with disease‑ associated protein aggregates. We also outline emerging translational opportunities, ranging from PrP‑derived peptide therapeutics to fluid-based biomarkers that track disease onset and progression.
2026
16
0
0
Goal 3: Good health and well-being
Mari E.; Aventaggiato M.; Paldino E.; Ceccarelli S.; Mucci N.; Bellomo G.; Mantuano E.; Dugheri S.; Martellucci S.; Mattei V.
File in questo prodotto:
File Dimensione Formato  
s13578-026-01609-9.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 2.08 MB
Formato Adobe PDF
2.08 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1500275
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact